Yvonne Briggs | LHA IR |
Dr. Phillip Frost | Chairman and CEO |
Steven Rubin | EVP |
Dr. Jon Cohen | SVP, Executive Chairman, BioReference Laboratories |
Adam Logal | CFO |
Charlie Bishop | CEO, OPKO Renal |
Maury Raycroft | Jefferies |
Devin Geiman | Guggenheim Partners |
Edward Tenthoff | Piper Sandler |
Yale Jen | Laidlaw and Company |
Yi Chen | HCW |
Mike Petusky | Barrington Research |
Ladies and gentlemen, thank you for standing by and welcome to the OPKO Health Fourth Quarter 2020 Financial Results Conference Call. At this time, all participant lines are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference to your speaker today, Yvonne Briggs at LHA Investor Relations.